期刊文献+

冠心病合并糖尿病患者药物洗脱支架置入术后远期疗效观察 被引量:4

Long-term outcomes in coronary heart disease patients with diabetes mellitus after drug-eluting stenting
下载PDF
导出
摘要 目的分析冠心病合并糖尿病患者药物洗脱支架(drug-eluting stent,DES)置入后远期有效性及安全性。方法在本院心内科2005年1月-2008年12月间行冠状动脉造影确诊为冠心病并行DES支架置入的646例患者根据有无合并糖尿病分为DES糖尿病组192例(随访183例,95.3%)与DES非糖尿病组454例(随访428例,94.3%),随访患者在DES置入后远期不良心血管事件(major adverse cardiac events,MACE)发生情况。结果糖尿病组合并高血压(75.4%vs 60.5%,P=0.00)及冠状动脉三支病变(47.0%vs 37.6%,P=0.05)、女性(26.2%vs 16.6%,P=0.01)比例高于非糖尿病组,单支病变(24.0%vs32.0%,P=0.05)比例及平均年龄小于非糖尿病组(60.08±11.58 vs 64.01±10.79,P=0.00)。两组MACE发生率比较差异无统计学意义,但随着术后时间延长,两组MACE率均呈递增趋势。两组支架内血栓发生率差异有统计学意义(2.7%vs 0.2%,P=0.02)。结论冠心病合并糖尿病患者较单纯冠心病患者多支病变比例及PCI术后确定的支架内血栓发生率高。DES术后两组MACE发生率均呈递增趋势,糖尿病组在极远期(>5年)增长更快。 Objective To analyze the long-term effect and safety of drug-eluting stent in patients with coronary heart disease(CHD) accompanying diabetes mellitus(DM).Methods Six hundred and forty-six patients who underwent drug-eluting stenting in our hospital from January 2005 to December 2008 were divided into CHD with DM group(n=192) and CHD without DM group(n=454). Of the 192 patients in CHD with DM group,183(95.3%) were followed up.Of the 454 patients in CHD without DM group,428(94.3%) were followed up.The incidence of major adverse cardiac events(MACE) was recorded in these followed up patients after drug-eluting stenting.Results The incidence of hypertension and lesions of 3 coronary branches was higher in CHD with DM group than in CHD without DM group(75.4% vs 60.5%,P=0.00;47.0% vs 37.6%,P=0.05).The proportion of female patients was higher in CHD with DM group than in CHD without DM group(26.2% vs 16.6%,P=0.01).The average age of CHD with DM group was younger than that of CHD without DM group 60.08±11.58 years vs 64.01±10.79 years,P=0.00).No significant difference was found in the incidence of MACE between the two groups.However,the incidence of MACE tended to increase with the time after operation in the two groups.The incidence of stent thrombosis was higher in CHD with DM group than in CHD without DM group(2.7% vs 0.2%,P=0.02).Conclusion The proportion of patients with CHD accompanying DM is higher than that of those not accompanying DM.The incidence of stent thrombosis is higher in patients with CHD accompanying DM than in those not accompanying DM.The incidence of MACE tends to increase after drug-eluting stenting,especially after 5 years.
出处 《解放军医学院学报》 CAS 2013年第5期428-430,471,共4页 Academic Journal of Chinese PLA Medical School
基金 "十二五"军队保健基金(11BG219)~~
关键词 药物洗脱支架 冠心病 糖尿病 安全性 drug-eluting stent coronary disease diabetes mellitus safety
  • 相关文献

参考文献11

  • 1YANG Yue-jin XU Bo KANG Sheng PEI Wei-dong CHEN Ji-lin QIAO Shu-bin QIN Xue-wen YAO Min CHEN Jue WU Yong-jian LIU Hai-bo YOU Shi-jie LI Jian-jun DAI Jun GAO Run-lin.Comparison of in-hospital and long-term outcomes between a Cypher stent and a Taxus stent in Chinese diabetic patients with coronary artery disease[J].Chinese Medical Journal,2007(21):1868-1873. 被引量:6
  • 2Stettler C,,Allemann S,Egger M,et al.Efficacy of drug eluting stents in patients without diabetes mellitus:indirect comparison controlled trials[].Heart.2006 被引量:1
  • 3Hong MK,Mintz GS,Lee CW,et a1.Late stent malapposition af-ter drug-eluting stent implantation:an intravascular ultrasoundanalysis with long-term follow-up[].Circulation.2006 被引量:1
  • 4Palmerini T,Dangas G,Mehran R,et al.Predictors and implications of stent thrombosis in non-ST-segment elevation acute coronary syn-dromes:the ACUITY Trial[].Circ Cardiovasc Interv.2011 被引量:1
  • 5R Zahn,CW Hamm,S Schneider,U Zeymer,G Richardt,M Kelm,B Levenson,T Bonzel,U Tebbe,G Sabin,CA Nienaber,J Senges.Predictors of death or myocardial infarction during follow-up after coronary stenting with the sirolimus-eluting stent. Results from the prospective multicenter German Cypher Stent Registry[].American Heart Journal.2006 被引量:1
  • 6ADVANCE Collaborative Group.Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes[].New England Journal of Medicine The.2008 被引量:1
  • 7Cutlip DE,,Windecker S,Mehran R,et al.Clinical end points in coronary stent trials:a case for standardized definitions[].Circulation.2007 被引量:1
  • 8R. Kumar,T.T. Lee,A. Jeremias.Comparison of outcomes using sirolimus-eluting stenting in diabetic versus nondiabetic patients with comparison of insulin versus noninsulin therapy in the diabetic patients[].The American Journal of Cardiology.2007 被引量:1
  • 9Raber L,Wohlwend L,Wigger M,et al.Five-year clinical andangiographic outcomes of a randomized comparison of sirolimus-eluting and paclitaxel-eluting stents:results of the Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascu-larization LATE trial[].Circulation.2011 被引量:1
  • 10Kimura T,Morimoto T,Nakagawa Y,et al.Very Late Stent Thrombosisand Late Target Lesion Revascularization After Sirolimus-Eluting StentImplantation: Five-Year Outcome of the j-Cypher Registry[].Circulation.2012 被引量:1

二级参考文献10

  • 1KANG Sheng YANG Yue-jin XU Bo CHEN Ji-lin QIAO Shu-bin YAO Min CHEN Jue WU Yong-jian LIU Hai-bo DAI Jun YUAN Jin-qing LI Jian-jun GAO Run-lin.Comparison of drug eluting stents with bare metal stents in daily practice for bifurcation lesions in Chinese patients[J].Chinese Medical Journal,2006(14):1157-1164. 被引量:10
  • 2Levin AD,Vukmirovic N,Hwang CW,Edelman ER.Specific binding to intracellular proteins determines arterial transport properties for rapamycin and paclitaxel[].Proceedings of the National Academy of Sciences of the United States of America.2004 被引量:1
  • 3Stettler C,Allemann S,Egger M,Windecker S,Meier B,Diem E.Efficacy of drug eluting stents in patients with and without diabetes mellitus:indirect comparison of randomised controlled trials[].Heart.2006 被引量:1
  • 4Gallo R,Padurean A,Jayaraman T,et al.Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle[].Circulation.1999 被引量:1
  • 5Stein,B,Weintraub,WS,Gebhart,SP,Cohen-Bernstein,CL,Grosswald,R,Liberman,H.,Jr,Douglas,JS,Morris,DC,3rd,King,SB.Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty[].Circulation.1995 被引量:1
  • 6Niles,N.W.,McGrath,P.D.,Malenka,D.Survival of patients with diabetes and multivessel coronary artery disease after surgical or percutaneous coronary revascularization: results of a large regional prospective study[].Journal of the American College of Cardiology.2001 被引量:1
  • 7Sabate M,Jimenez-Quevedo P,Angiolillo DJ,Gomez-Hospital JA,Alfonso F,Hernandez-Antolin R,Goicolea J,Banuelos C,Escaned J,Moreno R,Fernandez C,Fernandez-Aviles F,Macaya C.Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial[].Circulation.2005 被引量:1
  • 8Moussa,I,Leon,MB,Baim,DS,O’Neill,WW,Popma,JJ,Buchbinder,M.Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy[].Circulation.2004 被引量:1
  • 9Daemen J,Garcia-Garcia H M,Kukreja N,et al.The Long-Term Value of Sirolimusand Paclitaxel-Eluting Stents overBare Metal Stents in Patients with Diabetes Mellitus[].European Heart Journal.2007 被引量:1
  • 10Pramod K. Kuchulakanti MD,William W. Chu MD,PhD,Rebecca Torguson BS,Leonardo Clavijo MD,Roswitha Wolfram MD,Sundeep Mishra MD,Zhenyi Xue MS,Natalie Gevorkian MD,William O. Suddath MD,Lowell F. Satler MD,Kenneth M. Kent MD,Augusto D. Pichard MD.<i>Sirolimus</i>-Eluting Stents Versus <i>Paclitaxel</i>-Eluting Stents in the Treatment of Coronary Artery Disease in Patients With Diabetes Mellitus[].The American Journal of Cardiology.2006 被引量:1

共引文献5

同被引文献32

  • 1Moran A, Gu D, Zhao D, et al. Future cardiovascular disease in China : markov model and risk factor seenario projections from the coronary heart disease poliey model-china [ J ] . Cire Cardiovase Qual Outcomes, 2010, 3 ( 3 ) : 243-252. 被引量:1
  • 2Park KH, Ahn Y, Jeong MH, et al. Different impact of diabetes mellitus on in-hospital and 1-year mortality in patients with acute myocardial infarction who underwent successful percutaneous coronary intervention : results from the Korean Acute Myocardial Infarction Registry [ J ]. Korean J Intern Med, 2012, 27 ( 2 ) : 180-188. 被引量:1
  • 3Morice MC, Colombo A, Meier B, et al. Sirolimus- vs paclitaxel- eluting stents in de novo coronary artery lesions : the REALITY trial : a randomized controlled trim [J] ~ JAMA, 2006, 295 ( 8 ) : 895- 904. 被引量:1
  • 4Garber AJ, Abrahamson MJ, Barzilay JI, et al. American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement-executive summary [ J ] . Endocr Pract, 2013, 19 (3): 536-557. 被引量:1
  • 5Ellis SG, Guetta V, Miller D, et al. Relation between lesion characteristics and risk with percutaneous intervention in the stent and glyeoprotein IIb/IIIa era : An analysis of results from 10, 907 lesions and proposal for new classification scheme [ J ] . Circulation, 1999, 100 ( 19 ) : 1971-1976. 被引量:1
  • 6Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease [ J ] . N Engl J Med, 2009, 360 ( 10 ) : 961-972. 被引量:1
  • 7M ti ller P, Rosenkranz S, Adam O, et al. Clinical trial updates and hotline sessions presented at the European Society of Cardiology Congress 2008 [ J ]. Clin Res Cardiol, 2008, 97 ( 12 ) : 851-864. 被引量:1
  • 8Kappetein AP, Feldman TE, Mack M J, et al. Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease : 3-year follow-up of the SYNTAX trial [J] . Eur Heart J, 2011, 32 ( 17 ) : 2125-2134. 被引量:1
  • 9Frishman WH, Gomberg-Maitland M, Hirsch H, et al. Differences between male and female patients with regard to baseline demographics and clinical outcomes in the Asymptomatic Cardiac lschemia Pilot ( ACIP ) Trial [ J ] . Clin Cardiol, 1998, 21 ( 3 ) : 184-190. 被引量:1
  • 10Hoehner-Celnikier D, Manor O, Gotzman O, et al. Gender gap in coronary artery disease : comparison of the extent, severity and risk factors in men and women aged 45-65 years [J] . Cardiology, 2002, 97 ( 1 ) : 18-23. 被引量:1

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部